Lifecore Biomedical, Inc. \de\ SEC filings LFCR

Lifecore Biomedical, Inc. \de\ has 1,005 filings in SEC EDGAR's recent list, going back to May 16, 2012. Its latest annual report, Form 10-KT, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on May 25.

Form Description Filed Period
424B3 Prospectus Sep 30, 2025 —
S-3 Shelf registration Sep 23, 2025 —
S-8 Employee stock plan registration Aug 7, 2025 —
424B3 Prospectus Oct 23, 2024 —
S-8 Employee stock plan registration Oct 10, 2024 —
S-8 Employee stock plan registration Oct 10, 2024 —
S-1 Registration statement Oct 10, 2024 —
POS AM Filing Oct 10, 2024 —
424B3 Prospectus Jun 9, 2023 —
S-1/A Amended registration statement Jun 6, 2023 —
S-1 Registration statement Apr 6, 2023 —
S-8 Employee stock plan registration Apr 6, 2023 —
S-8 Employee stock plan registration Oct 16, 2019 —
S-8 Employee stock plan registration Oct 20, 2017 —
S-3 Shelf registration Oct 16, 2015 —
S-8 Employee stock plan registration Jan 7, 2014 —

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LFCR (Nasdaq)
Fiscal year ends
May 25
Incorporated in
DE
Headquarters
Chaska, MN
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1005286
Former names
LANDEC CORP \CA\ (until Nov 7, 2022)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.